AAV Gene Therapy Core | Vascular Medicine Institute

The AAV Gene Therapy Core at the Vascular Medicine Institute (VMI) is a research-focused organization based at the University of Pittsburgh. The institute conducts translational and clinical research with emphasis on cardiovascular and vascular diseases, including pulmonary hypertension and aortic valve disease. Research activities span early detection methodologies, therapeutic development, and biomarker discovery. The organization engages in multi-institutional collaborations and is led by experienced physician-scientists conducting NIH-funded research programs.